DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Ochiai H, Archer GE, Herndon 2nd JE. et al.
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.
Cancer Immunol Immunother 2008;
57: 115-121
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.